These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 22070213

  • 1. Prenatal high-dose immunoglobulin treatment for neonatal hemochromatosis: a case report and review of the literature.
    Tanaka H, Haba R, Itoh S, Sakamoto H, Hata T.
    J Obstet Gynaecol Res; 2011 Dec; 37(12):1891-4. PubMed ID: 22070213
    [Abstract] [Full Text] [Related]

  • 2. [Prenatal treatment of neonatal hemochromatosis with maternal administration of intravenous immunoglobulins (about four cases)].
    Paupe A, Duclos B, Leroy B, Molho M.
    Gynecol Obstet Fertil; 2011 Dec; 39(7-8):418-24. PubMed ID: 21742537
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Successful treatment of neonatal hemochromatosis as gestational alloimmune liver disease with intravenous immunoglobulin.
    Jimenez-Rivera C, Gupta A, Feberova J, de Nanassy JA, Boland MP.
    J Neonatal Perinatal Med; 2014 Dec; 7(4):301-4. PubMed ID: 25468619
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis.
    Whitington PF, Hibbard JU.
    Lancet; 2014 Dec; 364(9446):1690-8. PubMed ID: 15530630
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Japanese experience and pharmacokinetics of antenatal maternal high-dose immunoglobulin treatment as a prophylaxis for neonatal hemochromatosis in siblings.
    Okada N, Sasaki A, Saito J, Mitani Y, Yachie A, Takahashi H, Matsubara S, Tenkumo C, Tanaka H, Hata T, Motomura K, Nagasawa J, Wada Y, Sako M, Yamaguchi K, Matsumoto K, Nakamura H, Sago H, Mizuta K.
    J Matern Fetal Neonatal Med; 2020 Jan; 33(1):142-148. PubMed ID: 29890876
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [High-dose immunoglobulin during pregnancy for two patients with risk of recurrent neonatal haemochromatosis].
    Carrabin N, Cordier MP, Gaucherand P.
    J Gynecol Obstet Biol Reprod (Paris); 2007 Jun; 36(4):409-12. PubMed ID: 17446006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.